A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

NCT03599193 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Tazarotene Lotion, 0.1%
DRUG: Tazarotene Cream, 0.1%

Sponsor

Dr. Reddy's Laboratories Limited